These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20383943)
1. Bortezomib induces apoptosis in human neuroblastoma CHP126 cells. Luo P; Lin M; Lin M; Zhu D; Wang Z; Shen J; Yang B; He Q Pharmazie; 2010 Mar; 65(3):213-8. PubMed ID: 20383943 [TBL] [Abstract][Full Text] [Related]
2. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptotic cell death by mycelium extracts of Phellinus linteus in human neuroblastoma cells. Choi YH; Huh MK; Ryu CH; Choi BT; Jeong YK Int J Mol Med; 2004 Aug; 14(2):227-32. PubMed ID: 15254770 [TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway. Chung EJ; Moon SW; Jung SA; Cho YJ; Kim SW; Lee JH Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6232-7. PubMed ID: 20702821 [TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091 [TBL] [Abstract][Full Text] [Related]
7. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma. Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells. Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084 [TBL] [Abstract][Full Text] [Related]
9. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis. Brignole C; Marimpietri D; Pastorino F; Nico B; Di Paolo D; Cioni M; Piccardi F; Cilli M; Pezzolo A; Corrias MV; Pistoia V; Ribatti D; Pagnan G; Ponzoni M J Natl Cancer Inst; 2006 Aug; 98(16):1142-57. PubMed ID: 16912267 [TBL] [Abstract][Full Text] [Related]
10. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines. Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625 [TBL] [Abstract][Full Text] [Related]
11. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin]. Chen JF; Jin J Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325 [TBL] [Abstract][Full Text] [Related]
12. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. Furfaro AL; Piras S; Passalacqua M; Domenicotti C; Parodi A; Fenoglio D; Pronzato MA; Marinari UM; Moretta L; Traverso N; Nitti M Biochim Biophys Acta; 2014 Apr; 1842(4):613-22. PubMed ID: 24380881 [TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
14. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells. Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252 [TBL] [Abstract][Full Text] [Related]
15. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells. Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib as a therapeutic candidate for neuroblastoma. Armstrong MB; Schumacher KR; Mody R; Yanik GA; Opipari AW; Castle VP J Exp Ther Oncol; 2008; 7(2):135-45. PubMed ID: 18771087 [TBL] [Abstract][Full Text] [Related]
17. [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549]. Li XW; Yang JR Zhong Yao Cai; 2012 Feb; 35(2):248-53. PubMed ID: 22822672 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B. Ko BS; Chang TC; Chen CH; Liu CC; Kuo CC; Hsu C; Shen YC; Shen TL; Golubovskaya VM; Chang CC; Shyue SK; Liou JY Life Sci; 2010 Jan; 86(5-6):199-206. PubMed ID: 20006625 [TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway. Luo P; Lin M; Li L; Yang B; He Q PLoS One; 2011; 6(11):e27298. PubMed ID: 22087283 [TBL] [Abstract][Full Text] [Related]
20. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis. Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]